Skip to content
Disclosery

CITADEL ADVISORS LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on GSK, newest first. How the timeline and the estimate are built.

CITADEL ADVISORS LLC held 151,573 GSK shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 151,573 shares
    Change vs previous 13F +151,573 shares

    <0.01% of the 13F portfolio, value $7,945,456.

    13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
    Accepted , ingested

  2. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -214,099 shares

    13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-12-31
    13F 214,099 shares
    Change vs previous 13F +214,099 shares

    0.01% of the 13F portfolio, value $10,499,415.

    13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -121,685 shares

    13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2025-06-30
    13F 121,685 shares
    Change vs previous 13F -1,501,889 shares

    <0.01% of the 13F portfolio, value $4,672,704.

    13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,623,574 shares
    Change vs previous 13F +1,439,760 shares

    0.06% of the 13F portfolio, value $62,897,257.

    13F-HR 0000950123-25-005687 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 183,814 shares
    Change vs previous 13F -393,225 shares

    0.01% of the 13F portfolio, value $6,216,589.

    13F-HR 0000950123-25-002739 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 577,039 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $23,589,354.

    13F-HR 0000950123-24-011767 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).